 |
Analysts| Firm | Analyst | | BMO Capital Markets Corp. | Jim Birchenough, M.D. | | Canaccord Genuity | Salveen Richter | | Citi Investment Research | Yaron Werber, M.D. | | J.P. Morgan Securities, LLC | Cory Kasimov | | Jefferies & Company | Thomas Wei | | Leerink Swann, LLC | Marko Kozul, M.D. | | Oppenheimer & Co. Inc. | David Ferreiro, Ph.D | | Piper Jaffray | M. Ian Somaiya | | ROTH Capital Partners, LLC | Robert Hazlett | | Stifel, Nicolaus & Company, Inc. | Stephen Willey | | UBS Investment Research | Matthew Harrison | | Wells Fargo Securities, LLC | Brian Abrahams |
|
| Rigel Pharmaceuticals Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Rigel Pharmaceuticals Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Rigel Pharmaceuticals Inc. or its management. Rigel Pharmaceuticals Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. |
| |
rigel in the news
